Whether liver transplantation(LT)plays a role in the treatment of patients with hepatocellular carcinoma(HCC)in non-cirrhotic liver(NCL)is a matter of debate.The recommendations for LT in this setting are extremely fr...Whether liver transplantation(LT)plays a role in the treatment of patients with hepatocellular carcinoma(HCC)in non-cirrhotic liver(NCL)is a matter of debate.The recommendations for LT in this setting are extremely fragile and less welldefined than for cirrhosis-associated HCC.All reports of LT for NCL-HCC revealed that long-term outcomes of these patients are poor,and these dismal figures are justified by the advanced tumor stage at the time of LT,suggesting the presence of systemic micrometastatic disease.The decision-making regarding LT for NCL-HCC is difficult,since specific selection criteria are scarce,and basically the potential candidates are those with unresectable only-liver tumor at admission,or unresectable intrahepatic recurrence post-resection.Besides the surgical aspects regarding the tumor resectability,other phenotypic and genetic characteristics of the tumor should be considered for the indication of LT in this scenario.The present minireview aims to discuss and analyze the last series of LT for NCL-HCC,in order to help clinicians in the decision-making process regarding the role of LT in NCL-HCC treatment.展开更多
文摘Whether liver transplantation(LT)plays a role in the treatment of patients with hepatocellular carcinoma(HCC)in non-cirrhotic liver(NCL)is a matter of debate.The recommendations for LT in this setting are extremely fragile and less welldefined than for cirrhosis-associated HCC.All reports of LT for NCL-HCC revealed that long-term outcomes of these patients are poor,and these dismal figures are justified by the advanced tumor stage at the time of LT,suggesting the presence of systemic micrometastatic disease.The decision-making regarding LT for NCL-HCC is difficult,since specific selection criteria are scarce,and basically the potential candidates are those with unresectable only-liver tumor at admission,or unresectable intrahepatic recurrence post-resection.Besides the surgical aspects regarding the tumor resectability,other phenotypic and genetic characteristics of the tumor should be considered for the indication of LT in this scenario.The present minireview aims to discuss and analyze the last series of LT for NCL-HCC,in order to help clinicians in the decision-making process regarding the role of LT in NCL-HCC treatment.
